Next Generation Sequencing of Reactive Stroma and Residual Breast Cancer Cells in Tumor Bed after Neoadjuvant Chemotherapy

SIMPLE SUMMARY: Primary systemic or neoadjuvant chemotherapy of breast cancer has become a standard therapy option in locally advanced or triple negative or Her2 positive breast cancer. Neoadjuvant chemotherapy can result in complete pathological response without residual tumor cells (tumor bed) or...

Descripción completa

Detalles Bibliográficos
Autores principales: Varga, Zsuzsanna, Christiansen, Ailsa, Lukamowicz-Rajska, Magdalena, Batavia, Aashil A., von Teichman, Adriana, Schraml, Peter, Moch, Holger
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688915/
https://www.ncbi.nlm.nih.gov/pubmed/36428702
http://dx.doi.org/10.3390/cancers14225609

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688915/
https://www.ncbi.nlm.nih.gov/pubmed/36428702
http://dx.doi.org/10.3390/cancers14225609

Ejemplares similares